Literature DB >> 22850150

Noncompressible torso hemorrhage: a review with contemporary definitions and management strategies.

Jonathan J Morrison1, Todd E Rasmussen.   

Abstract

Trauma resulting in hemorrhage from vascular disruption within the torso is a challenging scenario, with a propensity to be lethal in the first hour following trauma. The term noncompressible torso hemorrhage (NCTH) was only recently coined as part of contemporary studies describing the epidemiology of wounding during the wars in Afghanistan and Iraq. This article provides a contemporary review of NCTH, including a unifying definition to promote future study as well as a description of resuscitative and operative management strategies to be used in this setting, and sets a course for research to improve mortality following this vexing injury pattern. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22850150     DOI: 10.1016/j.suc.2012.05.002

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  28 in total

Review 1.  The ebb and flow of fluid (as in resuscitation).

Authors:  K L Mattox
Journal:  Eur J Trauma Emerg Surg       Date:  2014-08-20       Impact factor: 3.693

2.  Management of intra-abdominal vascular injury in trauma laparotomy: a South African experience.

Authors:  Ross Weale; Victor Kong; Vassil Manchev; Wanda Bekker; George Oosthuizen; Petra Brysiewicz; Grant Laing; John Bruce; Damian Clarke
Journal:  Can J Surg       Date:  2018-06       Impact factor: 2.089

3.  Resuscitative endovascular balloon occlusion of the aorta (REBOA) and endovascular resuscitation and trauma management (EVTM): a paradigm shift regarding hemodynamic instability.

Authors:  Tal Hörer
Journal:  Eur J Trauma Emerg Surg       Date:  2018-08-06       Impact factor: 3.693

4.  Fixed-Distance Model for Balloon Placement During Fluoroscopy-Free Resuscitative Endovascular Balloon Occlusion of the Aorta in a Civilian Population.

Authors:  Pierre Pezy; Alexandros N Flaris; Nicolas J Prat; François Cotton; Peter W Lundberg; Jean-Louis Caillot; Jean-Stéphane David; Eric J Voiglio
Journal:  JAMA Surg       Date:  2017-04-01       Impact factor: 14.766

5.  Use of resuscitative balloon occlusion of the aorta in a swine model of prolonged cardiac arrest.

Authors:  Mohamad Hakam Tiba; Brendan M McCracken; Brandon C Cummings; Carmen I Colmenero; Chandler J Rygalski; Cindy H Hsu; Thomas H Sanderson; Brahmajee K Nallamothu; Robert W Neumar; Kevin R Ward
Journal:  Resuscitation       Date:  2019-05-20       Impact factor: 5.262

6.  Intravenous hemostatic nanoparticles increase survival following blunt trauma injury.

Authors:  Andrew J Shoffstall; Kristyn T Atkins; Rebecca E Groynom; Matthew E Varley; Lydia M Everhart; Margaret M Lashof-Sullivan; Blaine Martyn-Dow; Robert S Butler; Jeffrey S Ustin; Erin B Lavik
Journal:  Biomacromolecules       Date:  2012-10-08       Impact factor: 6.988

Review 7.  [Resuscitative endovascular balloon occlusion of the aorta : Option for incompressible trunk bleeding?]

Authors:  J Knapp; M Bernhard; T Haltmeier; D Bieler; B Hossfeld; M Kulla
Journal:  Anaesthesist       Date:  2018-04       Impact factor: 1.041

8.  A hydrogel sealant for the treatment of severe hepatic and aortic trauma with a dissolution feature for post-emergent care.

Authors:  Marlena D Konieczynska; Juan C Villa-Camacho; Cynthia Ghobril; Miguel Perez-Viloria; William A Blessing; Ara Nazarian; Edward K Rodriguez; Mark W Grinstaff
Journal:  Mater Horiz       Date:  2016-12-23       Impact factor: 13.266

Review 9.  Intravenous hemostats: challenges in translation to patients.

Authors:  Margaret Lashof-Sullivan; Andrew Shoffstall; Erin Lavik
Journal:  Nanoscale       Date:  2013-10-02       Impact factor: 7.790

10.  Tuning ligand density on intravenous hemostatic nanoparticles dramatically increases survival following blunt trauma.

Authors:  Andrew J Shoffstall; Lydia M Everhart; Matthew E Varley; Eric S Soehnlen; Adam M Shick; Jeffrey S Ustin; Erin B Lavik
Journal:  Biomacromolecules       Date:  2013-07-24       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.